• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-靶基因调控网络:一种用于生物标志物选择的贝叶斯整合方法及其在肾癌中的应用

miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.

作者信息

Chekouo Thierry, Stingo Francesco C, Doecke James D, Do Kim-Anh

机构信息

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, 1400 Pressler Street, Unit 1411, Texas, 77030-3722, U.S.A.

CSIRO Computational Informatics/Australian e-Health Research Centre Level 5, UQ Health Sciences Building, 901/16 Royal Brisbane, Queensland, 4029, Australia.

出版信息

Biometrics. 2015 Jun;71(2):428-38. doi: 10.1111/biom.12266. Epub 2015 Jan 30.

DOI:10.1111/biom.12266
PMID:25639276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4499566/
Abstract

The availability of cross-platform, large-scale genomic data has enabled the investigation of complex biological relationships for many cancers. Identification of reliable cancer-related biomarkers requires the characterization of multiple interactions across complex genetic networks. MicroRNAs are small non-coding RNAs that regulate gene expression; however, the direct relationship between a microRNA and its target gene is difficult to measure. We propose a novel Bayesian model to identify microRNAs and their target genes that are associated with survival time by incorporating the microRNA regulatory network through prior distributions. We assume that biomarkers involved in regulatory networks are likely associated with survival time. We employ non-local prior distributions and a stochastic search method for the selection of biomarkers associated with the survival outcome. We use KEGG pathway information to incorporate correlated gene effects within regulatory networks. Using simulation studies, we assess the performance of our method, and apply it to experimental data of kidney renal cell carcinoma (KIRC) obtained from The Cancer Genome Atlas. Our novel method validates previously identified cancer biomarkers and identifies biomarkers specific to KIRC progression that were not previously discovered. Using the KIRC data, we confirm that biomarkers involved in regulatory networks are more likely to be associated with survival time, showing connections in one regulatory network for five out of six such genes we identified.

摘要

跨平台大规模基因组数据的可用性使得对多种癌症复杂生物学关系的研究成为可能。识别可靠的癌症相关生物标志物需要对复杂遗传网络中的多种相互作用进行表征。微小RNA是调节基因表达的小非编码RNA;然而,微小RNA与其靶基因之间的直接关系很难测量。我们提出了一种新颖的贝叶斯模型,通过先验分布纳入微小RNA调控网络,来识别与生存时间相关的微小RNA及其靶基因。我们假设参与调控网络的生物标志物可能与生存时间相关。我们采用非局部先验分布和随机搜索方法来选择与生存结果相关的生物标志物。我们利用KEGG通路信息来纳入调控网络内的相关基因效应。通过模拟研究,我们评估了我们方法的性能,并将其应用于从癌症基因组图谱获得的肾透明细胞癌(KIRC)实验数据。我们的新方法验证了先前鉴定的癌症生物标志物,并鉴定出了先前未发现的KIRC进展特异性生物标志物。利用KIRC数据,我们证实参与调控网络的生物标志物更有可能与生存时间相关,在我们鉴定的六个此类基因中的五个基因中,显示出在一个调控网络中的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/057f8f5c74b6/nihms699572f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/114d74addcda/nihms699572f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/652c9f627bea/nihms699572f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/057f8f5c74b6/nihms699572f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/114d74addcda/nihms699572f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/652c9f627bea/nihms699572f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/4499566/057f8f5c74b6/nihms699572f3.jpg

相似文献

1
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.微小RNA-靶基因调控网络:一种用于生物标志物选择的贝叶斯整合方法及其在肾癌中的应用
Biometrics. 2015 Jun;71(2):428-38. doi: 10.1111/biom.12266. Epub 2015 Jan 30.
2
Identification of genes and pathways involved in kidney renal clear cell carcinoma.肾透明细胞癌相关基因和通路的鉴定
BMC Bioinformatics. 2014;15 Suppl 17(Suppl 17):S2. doi: 10.1186/1471-2105-15-S17-S2. Epub 2014 Dec 16.
3
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.通过泛癌筛选发现肾透明细胞癌生存时间的独特蛋白表达特征。
BMC Genomics. 2017 Oct 3;18(Suppl 6):678. doi: 10.1186/s12864-017-4026-6.
4
Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.基于长非编码 RNA 和 miRNA 竞争内源性网络分析鉴定的肾癌预后特征。
Oncol Rep. 2018 Aug;40(2):959-967. doi: 10.3892/or.2018.6476. Epub 2018 Jun 6.
5
Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.基于多组学整合的肾透明细胞癌免疫和炎症相关生物标志物的全面特征分析。
J Transl Med. 2019 May 27;17(1):177. doi: 10.1186/s12967-019-1927-y.
6
miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.miR-192、miR-194 和 miR-215:抑制肾细胞癌肿瘤进展的汇聚 miRNA 网络。
Carcinogenesis. 2013 Oct;34(10):2231-9. doi: 10.1093/carcin/bgt184. Epub 2013 May 28.
7
Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.蛋白质编码和非编码RNA的综合分析确定了透明细胞肾细胞癌的临床相关亚型。
Oncotarget. 2016 Dec 13;7(50):82671-82685. doi: 10.18632/oncotarget.12340.
8
A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.一种作为透明细胞肾癌诊断和预后标志物的三微小RNA特征:一项计算机分析。
PLoS One. 2017 Jun 29;12(6):e0180660. doi: 10.1371/journal.pone.0180660. eCollection 2017.
9
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.基于肾透明细胞癌中异常DNA甲基化鉴定预后生物标志物。
Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134.
10
Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.基于生物信息学分析鉴定肾透明细胞癌中的 METTL14
Dis Markers. 2019 Dec 30;2019:5648783. doi: 10.1155/2019/5648783. eCollection 2019.

引用本文的文献

1
Using prior-data conflict to tune Bayesian regularized regression models.利用先验数据冲突调整贝叶斯正则化回归模型。
Stat Comput. 2025;35(2):53. doi: 10.1007/s11222-025-10582-1. Epub 2025 Feb 20.
2
NetMIM: network-based multi-omics integration with block missingness for biomarker selection and disease outcome prediction.NetMIM:基于网络的多组学整合,具有块缺失,用于生物标志物选择和疾病结果预测。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae454.
3
Tutorial on survival modeling with applications to omics data.生存分析建模教程及其在组学数据中的应用。

本文引用的文献

1
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent.通过坐标下降法求解Cox比例风险模型的正则化路径
J Stat Softw. 2011 Mar;39(5):1-13. doi: 10.18637/jss.v039.i05.
2
Inferring probabilistic miRNA-mRNA interaction signatures in cancers: a role-switch approach.推断癌症中概率 miRNA-mRNA 相互作用特征:一种角色转换方法。
Nucleic Acids Res. 2014 May;42(9):e76. doi: 10.1093/nar/gku182. Epub 2014 Mar 7.
3
Bayesian Model Selection in High-Dimensional Settings.高维情形下的贝叶斯模型选择
Bioinformatics. 2024 Mar 4;40(3). doi: 10.1093/bioinformatics/btae132.
4
Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.通过组学研究试图理解头颈部癌症患者的口腔黏膜炎:叙事性综述。
Int J Mol Sci. 2023 Nov 30;24(23):16995. doi: 10.3390/ijms242316995.
5
Bayesian graphical models for modern biological applications.适用于现代生物学应用的贝叶斯图形模型。
Stat Methods Appt. 2022;31(2):197-225. doi: 10.1007/s10260-021-00572-8. Epub 2021 May 27.
6
Bayesian hierarchical lasso Cox model: A 9-gene prognostic signature for overall survival in gastric cancer in an Asian population.贝叶斯分层套索 Cox 模型:一种用于亚洲人群胃癌总生存期的 9 基因预后标志物。
PLoS One. 2022 Apr 14;17(4):e0266805. doi: 10.1371/journal.pone.0266805. eCollection 2022.
7
Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma.透明细胞肾细胞癌的五个微小RNA预后标志物构建及预后模型
Transl Cancer Res. 2021 May;10(5):2337-2353. doi: 10.21037/tcr-21-37.
8
The Application of Bayesian Methods in Cancer Prognosis and Prediction.贝叶斯方法在癌症预后和预测中的应用。
Cancer Genomics Proteomics. 2022 Jan-Feb;19(1):1-11. doi: 10.21873/cgp.20298.
9
Bayesian integrative analysis and prediction with application to atherosclerosis cardiovascular disease.贝叶斯综合分析和预测及其在动脉粥样硬化性心血管疾病中的应用。
Biostatistics. 2022 Dec 12;24(1):124-139. doi: 10.1093/biostatistics/kxab016.
10
MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.微小 RNA-200a 通过广泛的靶基因促进食管鳞状细胞癌细胞的增殖、迁移和侵袭。
Mol Med Rep. 2020 May;21(5):2073-2084. doi: 10.3892/mmr.2020.11002. Epub 2020 Feb 26.
J Am Stat Assoc. 2012;107(498). doi: 10.1080/01621459.2012.682536.
4
Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.非编码 RNA 与表观遗传学机制相互作用的临床意义:肿瘤学中的挑战与机遇。
Epigenetics. 2014 Jan;9(1):75-80. doi: 10.4161/epi.26488. Epub 2013 Oct 11.
5
A BAYESIAN GRAPHICAL MODELING APPROACH TO MICRORNA REGULATORY NETWORK INFERENCE.一种用于推断微小RNA调控网络的贝叶斯图形建模方法。
Ann Appl Stat. 2010;4(4):2024-2048. doi: 10.1214/10-AOAS360.
6
INCORPORATING BIOLOGICAL INFORMATION INTO LINEAR MODELS: A BAYESIAN APPROACH TO THE SELECTION OF PATHWAYS AND GENES.将生物信息整合到线性模型中:一种选择通路和基因的贝叶斯方法。
Ann Appl Stat. 2011 Sep 1;5(3):1978-2002. doi: 10.1214/11-AOAS463.
7
Suppression of mitochondrial complex I influences cell metastatic properties.抑制线粒体复合物 I 会影响细胞的转移特性。
PLoS One. 2013 Apr 22;8(4):e61677. doi: 10.1371/journal.pone.0061677. Print 2013.
8
MicroRNAs and lymphomagenesis: a functional review.MicroRNAs 与淋巴瘤发生:功能综述。
Br J Haematol. 2013 Mar;160(5):571-81. doi: 10.1111/bjh.12157. Epub 2012 Dec 4.
9
iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data.iBAG:高维多组学基因组数据的综合贝叶斯分析。
Bioinformatics. 2013 Jan 15;29(2):149-59. doi: 10.1093/bioinformatics/bts655. Epub 2012 Nov 9.
10
Joint analysis of miRNA and mRNA expression data.miRNA 和 mRNA 表达数据的联合分析。
Brief Bioinform. 2013 May;14(3):263-78. doi: 10.1093/bib/bbs028. Epub 2012 Jun 12.